Fidia Pharma

Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on Hyaluronic Acid (HA) in eye care, health & wellness care, joint care, skin care, specialty care. Over 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (~1,200 patents). Fidia extends its global reach through local partners in +120 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt, the Middle East and Turkey. Fidia has more than 1,700 global employees and boasts a turnover exceeding €510 million (2024), nearly 50 percent of which is generated abroad. At Fidia, we are committed to fostering a professional, informative, and respectful community. Our Social Media Netiquette ensures that discussions remain ethical, compliant, and valuable for everyone. Take a look at our Netiquette here: If you come across any content that breaches these rules, please report it to us directly: